Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Assessing Baxter (BAX) Valuation After Launch Of IV Verify Line Labeling System
Baxter International recently launched its IV Verify Line Labeling System, an automation tool for IV line identification, medication safety, and nurse workflow. Despite this innovation and a 5.6% gain in the last 7 days, the stock has experienced a 41.0% loss over the past year. Simply Wall St’s analysis suggests Baxter is currently undervalued by 23% with a fair value of $21.63, driven by ongoing portfolio optimization, cost reductions, and new leadership, but potential risks from margin pressures and product issues remain.